Showing results (1-10 of 2,983) with videos related to
Sort By:
Pageof 299
AIDS (London, England)|January 1, 1997
Viral load in asymptomatic patients with CD4+ lymphocyte counts above 500 x 10(6)/lF García, C Vidal, J M Gatell, et al.Antiviral Therapy|March 21, 2000
Early antiretroviral therapy: rationale, protease inhibitor-sparing regimens and once daily dosingJ M GatellRevista De Neurologia|December 1, 1996
[Antiretroviral treatment. Present and future of the combinations]J M Gatell-ArtigasCurrent Opinion in Infectious Diseases|October 13, 2006
Metabolic abnormalities and body fat redistribution in HIV-1 infected patients: the lipodystrophy syndromeE Martínez, J M GatellMedicina Clinica|May 8, 1999
[Disseminated cryptococcosis in patients with AIDS. Prognostic factors of poor outcome]M Alonso, F García, J Mallolas, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2000
Residual low-level viral replication could explain discrepancies between viral load and CD4+ cell response in human immunodeficiency virus-infected patients receiving antiretroviral therapyF García, C Vidal, M Plana, et al.The Journal of Antimicrobial Chemotherapy|February 14, 2004
Immunosuppressive drugs as an adjuvant to HIV treatmentEmilio Fumero, Felipe García, J M GatellJournal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2001
Preliminary data of a prospective study on neuropsychiatric side effects after initiation of efavirenzJ Blanch, E Martínez, A Rousaud, et al.Lancet (London, England)|September 18, 2001
Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort studyE Martinez, A Mocroft, M A García-Viejo, et al.Pageof 299